516 related articles for article (PubMed ID: 25000481)
1. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
2. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
3. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
5. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
6. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
Tan Q; Zhang L; Liu G; He D; Yin H; Wang H; Wu J; Liao H; Zhang J
Drug Dev Ind Pharm; 2013 Sep; 39(9):1364-71. PubMed ID: 22994163
[TBL] [Abstract][Full Text] [Related]
7. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
8. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
10. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
12. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
Tafere C; Yilma Z; Abrha S; Yehualaw A
PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet.
Liew KB; Peh KK
Arch Pharm Res; 2021 Aug; 44(8):1-10. PubMed ID: 25579848
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
[TBL] [Abstract][Full Text] [Related]
15. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method.
Randale SA; Dabhi CS; Tekade AR; Belgamwar VS; Gattani SG; Surana SJ
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):443-8. PubMed ID: 20410620
[TBL] [Abstract][Full Text] [Related]
16. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
[TBL] [Abstract][Full Text] [Related]
18. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
Nakano Y; Maeda A; Uchida S; Namiki N
Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.
Comoglu T; Inal O; Yaacoub HB
Pharm Dev Technol; 2016 Dec; 21(8):901-908. PubMed ID: 25798913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]